Severe asthma requires regular medical assessment as death may occur. Patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and PEF values below 60% predicted at baseline with greater than 30% variability, usually not returning entirely to normal after a bronchodilator. These patients will require high dose inhaled or oral corticosteroid therapy. Sudden worsening of symptoms may require increased corticosteroid dosage which should be administered under urgent medical supervision.
BECLATE ROTACAPS is contraindicated in patients with a history of hypersensitivity to any of the components of the drug product.
Special care is necessary in patients with active or quiescent pulmonary tuberculosis.